These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2172200

  • 1. Beta-lactamase inhibitors and Acinetobacter spp.
    Eng RH, Smith SM, Cherubin CE.
    J Antimicrob Chemother; 1990 Sep; 26(3):449-51. PubMed ID: 2172200
    [No Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S, Marre R.
    Infection; 1991 Sep; 19(2):106-9. PubMed ID: 1646771
    [Abstract] [Full Text] [Related]

  • 3. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J, Hupková M, Krcméry V.
    Cas Lek Cesk; 1995 Sep 06; 134(17):558-61. PubMed ID: 7553760
    [Abstract] [Full Text] [Related]

  • 4. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
    Prabhakaran K, Harris EB, Randhawa B, Adams LB, Williams DL, Hastings RC.
    Microbios; 1993 Sep 06; 76(309):251-61. PubMed ID: 8302203
    [Abstract] [Full Text] [Related]

  • 5. Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
    WaKabongo M, Stucki ZN, Torbert DP, Olweny J.
    J Am Osteopath Assoc; 2005 Jan 06; 105(1):25-6. PubMed ID: 15710671
    [No Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).
    Eliopoulos GM, Klimm K, Ferraro MJ, Jacoby GA, Moellering RC.
    Diagn Microbiol Infect Dis; 1989 Jan 06; 12(6):481-8. PubMed ID: 2560420
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of YTR 830.
    Jacobs MR, Aronoff SC, Appelbaum PC, Yamabe S.
    J Chemother; 1989 Jun 06; 1(3):151-4. PubMed ID: 2552029
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
    Kuck NA, Jacobus NV, Petersen PJ, Weiss WJ, Testa RT.
    Antimicrob Agents Chemother; 1989 Nov 06; 33(11):1964-9. PubMed ID: 2558615
    [Abstract] [Full Text] [Related]

  • 9. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
    Aronoff SC, Jacobs MR, Johenning S, Yamabe S.
    Antimicrob Agents Chemother; 1984 Oct 06; 26(4):580-2. PubMed ID: 6097169
    [Abstract] [Full Text] [Related]

  • 10. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M, Moittie D, Philippon A, Descamps P, Veron M.
    J Antimicrob Chemother; 1989 May 06; 23(5):798-800. PubMed ID: 2547748
    [No Abstract] [Full Text] [Related]

  • 11. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr 06; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

  • 12. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb 06; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
    Suh B, Shapiro T, Jones R, Satishchandran V, Truant AL.
    Diagn Microbiol Infect Dis; 1995 Feb 06; 21(2):111-4. PubMed ID: 7628190
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.
    Higashitani F, Hyodo A, Ishida N, Inoue M, Mitsuhashi S.
    J Antimicrob Chemother; 1990 Apr 06; 25(4):567-74. PubMed ID: 2161820
    [Abstract] [Full Text] [Related]

  • 15. Antibacterial activity of clavulanate and tazobactam on Peptostreptococcus spp.
    Reig M, Baquero F.
    J Antimicrob Chemother; 1994 Feb 06; 33(2):358-9. PubMed ID: 8182024
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
    Higgins PG, Wisplinghoff H, Stefanik D, Seifert H.
    Antimicrob Agents Chemother; 2004 May 06; 48(5):1586-92. PubMed ID: 15105109
    [Abstract] [Full Text] [Related]

  • 17. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M, Barry A, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Mar 06; 12(3):200-5. PubMed ID: 8389705
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM, Seetulsingh P.
    J Antimicrob Chemother; 1991 Jun 06; 27(6):761-7. PubMed ID: 1669013
    [Abstract] [Full Text] [Related]

  • 19. Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.
    Reguera JA, Baquero F, Pérez-Díaz JC, Martínez JL.
    J Antimicrob Chemother; 1991 May 06; 27(5):569-75. PubMed ID: 1653204
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.
    Fuchs PC, Barry AL, Pfaller MA, Hardy DJ, McLaughlin JC, Gerlach EH.
    Diagn Microbiol Infect Dis; 1993 May 06; 17(2):171-5. PubMed ID: 8243040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.